Global Cytokine Profiles and Association With Clinical Characteristics in Patients With Irritable Bowel Syndrome (Q40642008)

22 September 2017

title

Global Cytokine Profiles and Association With Clinical Characteristics in Patients With Irritable Bowel Syndrome (English)

1 reference

22 September 2017

8

Magnus Simrén

1 reference

22 September 2017

Sean M P Bennet

1

1 reference

22 September 2017

Annikka Polster

2

1 reference

22 September 2017

Hans Törnblom

3

1 reference

22 September 2017

Stefan Isaksson

4

1 reference

22 September 2017

Sandrine Capronnier

5

1 reference

22 September 2017

Aurore Tessier

6

1 reference

22 September 2017

Boris Le Nevé

7

1 reference

22 September 2017

Lena Öhman

9

1 reference

22 September 2017

language of work or name

English

0 references

publication date

7 June 2016

1 reference

The American Journal of Gastroenterology

22 September 2017

published in

1 reference

22 September 2017

volume

111

1 reference

22 September 2017

issue

8

1 reference

22 September 2017

page(s)

1165-1176

1 reference

Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.223

AGA technical review on irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.223

Markers for visceral hypersensitivity in patients with irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.223

Immune activation in irritable bowel syndrome: can neuroimmune interactions explain symptoms?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.223

Elevated human beta-defensin-2 levels indicate an activation of the innate immune system in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.223

Immune activation in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.223

T-cell activation in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.223

Mucosal mast cell counts correlate with visceral hypersensitivity in patients with diarrhea predominant irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.223

Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.223

Enhanced cholinergic-mediated increase in the pro-inflammatory cytokine IL-6 in irritable bowel syndrome: role of muscarinic receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.223

Circulating cytokine signatures in healthy medical students exposed to academic examination stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.223

Cytokine Response after Stimulation with Key Commensal Bacteria Differ in Post-Infectious Irritable Bowel Syndrome (PI-IBS) Patients Compared to Healthy Controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.223

Cytokines and irritable bowel syndrome: where do we stand?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.223

Cytokine imbalance in irritable bowel syndrome: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.223

Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.223

Plasma cytokine profiles in females with irritable bowel syndrome and extra-intestinal co-morbidity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.223

Altered peripheral toll-like receptor responses in the irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.223

Serum and colonic mucosal immune markers in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.223

Mucosal cytokine imbalance in irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.223

Subclinical mucosal inflammation in diarrhea-predominant irritable bowel syndrome (IBS) in a tropical setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.223

Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.223

CD4+CD25+ regulatory T cells in irritable bowel syndrome patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.223

Mucosal immune cell numbers and visceral sensitivity in patients with irritable bowel syndrome: is there any relationship?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.223

Cytokines sing the blues: inflammation and the pathogenesis of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.223

Abdominal pain in Irritable Bowel Syndrome: a review of putative psychological, neural and neuro-immune mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.223

Modulation of enteric neurons by interleukin-6 and corticotropin-releasing factor contributes to visceral hypersensitivity and altered colonic motility in a rat model of irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.223

Functional bowel disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.223

Distinctive clinical, psychological, and histological features of postinfective irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.223

Barostat testing of rectal sensation and compliance in humans: comparison of results across two centres and overall reproducibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.223

Colonic transit time and IBS symptoms: what's the link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.223

The hospital anxiety and depression scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.223

The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.223

Imbalanced shift of cytokine expression between T helper 1 and T helper 2 (Th1/Th2) in intestinal mucosa of patients with post-infectious irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.223

The effects of psychological stress on humans: increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.223

Lower serum IL-10 is an independent predictor of IBS among volunteers in Mexico.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.223

Randomised controlled trial of mesalazine in IBS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.223

A mechanistic multicentre, parallel group, randomised placebo-controlled trial of mesalazine for the treatment of IBS with diarrhoea (IBS-D).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.223

A controlled study of colonic immune activity and beta7+ blood T lymphocytes in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.223

Putative inflammatory and immunological mechanisms in functional bowel disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.223

Activation of the mucosal immune system in irritable bowel syndrome

21 January 2018

1 reference

12 December 2020

The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress

1 reference

12 December 2020

Systemic lipopolysaccharide influences rectal sensitivity in rats: role of mast cells, cytokines, and vagus nerve

1 reference

12 December 2020

Decreased interleukin-10 secretion by peripheral blood mononuclear cells in children with irritable bowel syndrome

1 reference

12 December 2020

Pro-inflammatory and anti-inflammatory cytokine response in diarrhoea-predominant irritable bowel syndrome patients.

1 reference

12 December 2020

The expression of mucosal IL-1β, TNFα and serotonin transporter in chronic visceral hypersensitivity rats

1 reference

12 December 2020

Collagenous, microscopic and lymphocytic colitis. An evolving concept

1 reference

12 December 2020

Irritable bowel syndrome immune hypothesis. Part two: the role of cytokines.

1 reference

12 December 2020

Identifiers

DOI

10.1038/AJG.2016.223

1 reference

22 September 2017

1 reference